{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:07:38Z","timestamp":1776481658026,"version":"3.51.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gallbladder disease (GBD) can increase the risk of cardiovascular disease (CVD). However, GBD has rarely been reported in the less developed, rural areas of Xinjiang. This study aimed to determine the prevalence of GBD and incidence of CVD in a prospective cohort study in rural Xinjiang. Moreover, the study aimed to explore the association between GBD and CVD within this cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study cohort included 11,444 Uyghur adults in Xinjiang, 3<jats:sup>rd<\/jats:sup> division, from the 51st Mission. Study groups were classified according to whether GBD was present or absent at baseline. The occurrence of CVD was the end event. Demographic, anthropometric, and biochemical data were recorded, and the incidence of CVD in the GBD and non-GBD groups analysed. Cox proportional hazards regression models were used to assess the association between GBD and CVD and factors associated with their incidence. Several subgroup analyses were performed to assess CVD incidence in different subgroups. The interaction between GBD and cardiometabolic risk factors, and subsequent risk of developing CVD, was evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Prevalence of GBD in the study cohort was 10.29%. After a median follow-up of 4.92\u00a0years, the cumulative incidence of CVD in the study cohort was 10.49%, 8.43% in males and 12.65% in females. CVD incidence was higher in the GBD group (34.04% vs. 7.78%, HR\u2009=\u20094.96, 95% CI: 4.40\u20135.59). After multivariate adjustment, the risk of CVD remained higher in the GBD group (HR\u2009=\u20092.89, 95% CI: 2.54\u20133.29). Subgroup analyses showed male sex, smoking, alcohol consumption, lack of exercise, and abnormal renal function were all associated with increased risk of CVD. Moreover, the risk of CVD was markedly higher in GBD combined with cardiometabolic risk factors (hypertension, T2DM, dyslipidaemia, overweight, and abdominal obesity), than in cardiometabolic risk factors alone and this was higher in the GBD group than in the non-GBD group regardless of whether cardiometabolic risk factors were combined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>GBD is an important independent risk factor for CVD development. Awareness of these associations will raise concerns among clinicians about the risk of cardiovascular disease in patients with GBD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-15098-9","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:03:54Z","timestamp":1675469034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gallbladder disease is associated with the risk of cardiovascular disease among Uyghurs in Xinjiang: a prospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Rong","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"issue":"10","key":"15098_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/jhh.2017.43","volume":"31","author":"JY Wang","year":"2017","unstructured":"Wang JY, Lu FH, Sun ZJ, Wu JS, Yang YC, Lee CT, et al. Gallstone disease associated with increased risk of arterial stiffness in a Taiwanese population. J Hum Hypertens. 2017;31(10):616\u20139.","journal-title":"J Hum Hypertens"},{"issue":"11","key":"15098_CR2","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1111\/jgh.14264","volume":"33","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Xu M, Heianza Y, Ma W, Wang T, Sun D, et al. Gallstone disease and increased risk of mortality: two large prospective studies in US men and women. J Gastroenterol Hepatol. 2018;33(11):1925\u201331.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"15098_CR3","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/ATVBAHA.116.307507","volume":"36","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Xu M, Li Y, Hruby A, Rimm EB, Hu FB, et al. Gallstones and risk of coronary heart disease: prospective analysis of 270 000 men and women from 3 US cohorts and meta-analysis. Arterioscler Thromb Vasc Biol. 2016;36(9):1997\u20132003.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"15098_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/2047487313512218","volume":"22","author":"J Wirth","year":"2015","unstructured":"Wirth J, di Giuseppe R, Wientzek A, Katzke VA, Kloss M, Kaaks R, et al. Presence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study. Eur J Prev Cardiol. 2015;22(3):326\u201334.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"15098_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1155\/2002\/787598","volume":"16","author":"M Rp","year":"2002","unstructured":"Rp M, Ea S, Pl B. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol. 2002;16(3):187\u201394.","journal-title":"Can J Gastroenterol"},{"key":"15098_CR6","doi-asserted-by":"publisher","first-page":"693245","DOI":"10.3389\/fmed.2021.693245","volume":"8","author":"YJ Lee","year":"2021","unstructured":"Lee YJ, Park B, Hong KW, Jung DH. Gallbladder polyps increase the risk of ischaemic heart disease among Korean adults. Front Med (Lausanne). 2021;8:693245.","journal-title":"Front Med (Lausanne)"},{"key":"15098_CR7","doi-asserted-by":"publisher","first-page":"103668","DOI":"10.1016\/j.amsu.2022.103668","volume":"78","author":"M Sarago","year":"2022","unstructured":"Sarago M, Fiore D, De Rosa S, Amaddeo A, Pulitano L, Bozzarello C, et al. Acute acalculous cholecystitis and cardiovascular disease, which came first? After two hundred years still the classic chicken and eggs debate: A review of literature. Ann Med Surg (Lond). 2022;78:103668.","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"15098_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1665-2681(19)31490-5","volume":"11","author":"NC Chavez-Tapia","year":"2012","unstructured":"Chavez-Tapia NC, Mac Kinney-Novelo I, Sifuentes-Renter\u00cda SE, Torres-Zavala M, Castro-Gastelum G, S\u00e1nchez-Lara K, et al. Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann Hepatol. 2012;11(1):85\u20139.","journal-title":"Ann Hepatol"},{"issue":"1","key":"15098_CR9","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1038\/s41598-019-42327-2","volume":"9","author":"CJ Fairfield","year":"2019","unstructured":"Fairfield CJ, Wigmore SJ, Harrison EM. Gallstone disease and the risk of cardiovascular disease. Sci Rep. 2019;9(1):5830.","journal-title":"Sci Rep"},{"issue":"11","key":"15098_CR10","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/ijerph15112596","volume":"15","author":"Q Kang","year":"2018","unstructured":"Kang Q, Kang G, Li R, Zhu X, Yu Y, Yu Q. Relationship of Gallbladder Diseases with Sociodemographic Characteristics, Lifestyle, and Chronic Diseases in Northeastern China. Int J Environ Res Public Health. 2018;15(11):2596.","journal-title":"Int J Environ Res Public Health."},{"issue":"27","key":"15098_CR11","first-page":"2881","volume":"19","author":"XM Sun","year":"2011","unstructured":"Sun XM, Xu P, Ma ZH, Cheng XS, Zhu JL, He GJ, et al. Epidemiological survey of 30,901 cases of benign gallbladder diseases in Songjiang area Shanghai World. J Chin Digest. 2011;19(27):2881\u20135.","journal-title":"J Chin Digest"},{"issue":"08","key":"15098_CR12","first-page":"1352","volume":"9","author":"M Chen","year":"2015","unstructured":"Chen M, Zhang T, Kelemu, Zhang C, Arieh. Analysis of the current situation and characteristics of gallbladder stones among Uyghurs and Han Chinese. Chin J Clin Pract. 2015;9(08):1352\u20138.","journal-title":"Chin J Clin Pract."},{"issue":"03","key":"15098_CR13","first-page":"211","volume":"34","author":"J He","year":"2018","unstructured":"He J, Guo C, Ma RL, Liu JM, Ding Y, Zhang JY, et al. Study on the prevalence rate and optimal waist circumference cut-off points of obesity for the components of metabolic syndrome in Uygur from Xinjiang. Chin J Endocrinol Metab. 2018;34(03):211\u20136.","journal-title":"Chin J Endocrinol Metab."},{"issue":"10","key":"15098_CR14","first-page":"1288","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Xue ZX, Li YH, Wang YZ, Zhang ZB, Yuan J. Incidence and associated risk factors of diabetes mellitus among Uygur adult residents in Kashgar of South Xinjiang. J Trop Med. 2019;19(10):1288\u201391.","journal-title":"J Trop Med"},{"key":"15098_CR15","volume-title":"Analysis of the prevalence and five-year trends of adult obesity and cardiovascular metabolic indicators in Tacheng prefecture of Xinjiang","author":"CJ Guo","year":"2021","unstructured":"Guo CJ. Analysis of the prevalence and five-year trends of adult obesity and cardiovascular metabolic indicators in Tacheng prefecture of Xinjiang. China Medical University, Liaoning, China: Ph.D. Thesis; 2021."},{"key":"15098_CR16","volume-title":"Guidelines for controlling and monitoring the tobacco epidemic","author":"World Health O","year":"1998","unstructured":"World Health O. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization; 1998."},{"issue":"05","key":"15098_CR17","first-page":"606","volume":"37","author":"B Feng","year":"2016","unstructured":"Feng B, Chen JC, Li Y, Huang JF, Li JX, Zhao LC, et al. Relationship between overweight\/obesity and hypertension among adults in China: a prospective study. Chin J Epidemio. 2016;37(05):606\u201311.","journal-title":"Chin J Epidemio"},{"issue":"1","key":"15098_CR18","first-page":"24","volume":"24","author":"Writing Group of 2018 Chinese Guidelines for the Management of Hypertension Chinese Hypertension League Chinese Society of Cardiology","year":"2019","unstructured":"Writing Group of 2018 Chinese Guidelines for the Management of Hypertension Chinese Hypertension League Chinese Society of Cardiology, et al. 2018 Chinise guidelines management of hypertension. Chin J Cardiovasc Med. 2019;24(1):24\u201356.","journal-title":"Chin J Cardiovasc Med"},{"issue":"4","key":"15098_CR19","first-page":"292","volume":"38","author":"Chinese Diabetes Society","year":"2018","unstructured":"Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Chin J Pract Inter Med. 2018;38(4):292\u2013344.","journal-title":"Chin J Pract Inter Med"},{"key":"15098_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0065-2423(10)50003-9","volume":"50","author":"F Massimo","year":"2010","unstructured":"Massimo F, Giovanni T, Giuseppe L. Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? Adv Clin Chem. 2010;50:47\u201363.","journal-title":"Adv Clin Chem"},{"issue":"10","key":"15098_CR21","first-page":"937","volume":"31","author":"JR Chu","year":"2016","unstructured":"Chu JR, Gao RL, Zhao SP, Lu GP, Zhao D, Li JJ. 2016 Chinese guideline for the management of dyslipidemia in adults. Chin Circul J. 2016;31(10):937\u201353.","journal-title":"Chin Circul J"},{"key":"15098_CR22","first-page":"1","volume":"01","author":"Working Group on Obesity in China","year":"2004","unstructured":"Working Group on Obesity in China. Guidelines for the prevention and control of overweight and obesity in Chinese adults (excerpt). Acta Nutrimenta Sinica. 2004;01:1\u20134.","journal-title":"Acta Nutrimenta Sinica"},{"issue":"4","key":"15098_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2459\/JCM.0000000000000926","volume":"21","author":"A Mandurino-Mirizzi","year":"2020","unstructured":"Mandurino-Mirizzi A, Demarchi A, Ruffinazi M, Cornara S, Somaschini A, Crimi G, et al. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. J Cardiovasc Med. 2020;21(4):337\u20139.","journal-title":"J Cardiovasc Med"},{"issue":"5","key":"15098_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2459\/JCM.0000000000000634","volume":"19","author":"A Mandurino-Mirizzi","year":"2018","unstructured":"Mandurino-Mirizzi A, Crimi G, Raineri C, Pica S, Ruffinazzi M, Gianni U, et al. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Cardiovasc Med (Hagerstown). 2018;19(5):240\u20136.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"9","key":"15098_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AL, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"key":"15098_CR26","volume-title":"International statistical classification of diseases and related health problems","author":"World Health O","year":"2015","unstructured":"World Health O. International statistical classification of diseases and related health problems. Geneva: World Health Organization; 2015."},{"issue":"12","key":"15098_CR27","first-page":"8","volume":"26","author":"DK Lormand","year":"2019","unstructured":"Lormand DK, Williams VF, Fedgo A, Stahlman S. Update: gallbladder disease and cholecystectomies, active component, U.S. Armed forces, 2014\u20132018. Armed Forces. 2019;26(12):8\u201313.","journal-title":"Armed Forces."},{"issue":"2","key":"15098_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/nu11020335","volume":"11","author":"CM Chang","year":"2019","unstructured":"Chang CM, Chiu THT, Chang CC, Lin MN, Lin CL. Plant-based diet, cholesterol, and risk of gallstone disease: a prospective study. Nutrients. 2019;11(2):335.","journal-title":"Nutrients."},{"issue":"3","key":"15098_CR29","first-page":"137","volume":"12","author":"E Je","year":"2001","unstructured":"Je E. Gallstones and ethnicity in the Americas. J Assoc Acad Minor Phys. 2001;12(3):137\u201343.","journal-title":"J Assoc Acad Minor Phys"},{"issue":"2","key":"15098_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"S Lm","year":"2012","unstructured":"Lm S, Ea S. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut liver. 2012;6(2):172\u201387.","journal-title":"Gut liver"},{"issue":"6","key":"15098_CR31","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/hep.31212","volume":"72","author":"H Wang","year":"2020","unstructured":"Wang H, de Bari O, Arnatt C, Liu M, Portincasa P, Wang D. Activation of estrogen receptor g protein-coupled receptor 30 enhances cholesterol cholelithogenesis in female mice. Hepatology. 2020;72(6):2077\u201389.","journal-title":"Hepatology"},{"key":"15098_CR32","first-page":"118","volume":"01","author":"JX Li","year":"2016","unstructured":"Li JX, Chang QL. Xinjiang Uyghur populated areas analysis of the marriage and fertility situation of the population. N W J Ethnol. 2016;01:118\u201328.","journal-title":"N W J Ethnol"},{"issue":"7","key":"15098_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/sj.bjc.6605597","volume":"102","author":"G Andreotti","year":"2010","unstructured":"Andreotti G, Hou L, Gao YT, Brinton LA, Rashid A, Chen J, et al. Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai. China Br J Cancer. 2010;102(7):1185\u20139.","journal-title":"China Br J Cancer"},{"key":"15098_CR34","volume-title":"A prospective cohort study on the relationship between tea and milk intake and cardiovascular disease in the Chinese population","author":"XY Wang","year":"2020","unstructured":"Wang XY. A prospective cohort study on the relationship between tea and milk intake and cardiovascular disease in the Chinese population. Peking Union Medical College, Beijing, China: Ph.D Thesis; 2020."},{"issue":"09","key":"15098_CR35","first-page":"695","volume":"46","author":"XY Han","year":"2018","unstructured":"Han XY, Qi Y, Zhao D, Wang W, Wang M, Sun JY, et al. Association between long-term blood pressure change and the incidence of cardiovascular diseases: a population-based cohort study. Chin J Cardiol. 2018;46(09):695\u2013700.","journal-title":"Chin J Cardiol"},{"issue":"1","key":"15098_CR36","first-page":"88","volume":"21","author":"GD Kang","year":"2012","unstructured":"Kang GD, Guo L, Zhi-Rong G, Shu HuX, Wu M, Yang HT. Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population. Asia Pac J Clin Nutr. 2012;21(1):88\u201396.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"15098_CR37","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12889-020-09157-8","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Minzhang C, Minghui M, Xinmiao H, Laixin L, Bei W, et al. Improvement of long-term risks of cardiovascular events associated with community-based disease management in Chinese patients of the Xinjiang autonomous region of China. BMC Public Health. 2020;20(1):1034.","journal-title":"BMC Public Health."},{"issue":"25","key":"15098_CR38","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program Expert Panel on Detection E","year":"2002","unstructured":"National Cholesterol Education Program Expert Panel on Detection E. Treatment of high blood cholesterol in a third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"issue":"2","key":"15098_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/ijerph13020235","volume":"13","author":"QJ Chen","year":"2016","unstructured":"Chen QJ, Lai HM, Chen BD, Li XM, Zhai H, He CH, et al. Appropriate LDL-C-to-HDL-C ratio cutoffs for categorization of cardiovascular disease risk factors among Uygur Adults in Xinjiang, China. Int J Environ Res Public Health Rep. 2016;13(2):235.","journal-title":"Int J Environ Res Public Health Rep"},{"key":"15098_CR40","volume-title":"Molecular mechanism and function of APLP2 gene variants involved in cholesterol metabolism","author":"A Jalin","year":"2021","unstructured":"Jalin A. Molecular mechanism and function of APLP2 gene variants involved in cholesterol metabolism. Xinjiang Medical University, Xinjiang, China: Ph.D. Thesis; 2021."},{"issue":"10","key":"15098_CR41","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/ATVBAHA.115.306043","volume":"35","author":"J Lv","year":"2015","unstructured":"Lv J, Qi L, Yu C, Guo Y, Bian Z, Chen Y, et al. Gallstone disease and the risk of ischemic heart disease. Arterioscler Thromb Vasc Biol. 2015;35(10):2232\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"15098_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.21037\/atm.2019.11.114","volume":"7","author":"CH Chen","year":"2019","unstructured":"Chen CH, Lin CL, Kao CH. The risk of coronary heart disease after diagnosis of gallbladder polyp: a retrospective nationwide population-based cohort study. Ann Transl Med. 2019;7(23):753.","journal-title":"Ann Transl Med"},{"issue":"2","key":"15098_CR43","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1053\/j.gastro.2010.10.060","volume":"140","author":"R Ce","year":"2011","unstructured":"Ce R, Je E. Gallstone disease is associated with increased mortality in the United States. Gastroenterology. 2011;140(2):508\u201316.","journal-title":"Gastroenterology"},{"issue":"1","key":"15098_CR44","doi-asserted-by":"publisher","first-page":"15104","DOI":"10.1038\/s41598-017-15430-5","volume":"7","author":"LL Fan","year":"2017","unstructured":"Fan LL, Chen BH, Dai ZJ. The relation between gallstone disease and cardiovascular disease. Sci Rep. 2017;7(1):15104.","journal-title":"Sci Rep"},{"issue":"10","key":"15098_CR45","first-page":"541","volume":"52","author":"MJ Krasna","year":"1986","unstructured":"Krasna MJ, Flancbaum L. Electrocardiographic changes in cardiac patients with acute gallbladder disease. Am Surg. 1986;52(10):541\u20133.","journal-title":"Am Surg"},{"issue":"2","key":"15098_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/qjmed\/hcp156","volume":"103","author":"J Seewoodhary","year":"2010","unstructured":"Seewoodhary J, Griffin L. Trifascicular block and a raised Troponin \u201cT\u201d in acute cholecystitis. QJM. 2010;103(2):121\u20133.","journal-title":"QJM"},{"issue":"2","key":"15098_CR47","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000339965","volume":"6","author":"MS Demarchi","year":"2012","unstructured":"Demarchi MS, Regusci L, Fasolini F. Electrocardiographic changes and false-positive troponin I in a patient with acute cholecystitis. Case Rep Gastroenterol. 2012;6(2):410\u20134.","journal-title":"Case Rep Gastroenterol"},{"issue":"1","key":"15098_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/bmjnph-2019-000050","volume":"3","author":"L Ben-Yacob","year":"2020","unstructured":"Ben-Yacob L, Ainembabazi P, Stark AH, Kizito S, Bahendeka S. Prevalence and sex-specific patterns of metabolic syndrome in rural Uganda. BMJ Nutr, Prev Health Educ Behav. 2020;3(1):11\u20137.","journal-title":"BMJ Nutr, Prev Health Educ Behav"},{"issue":"Suppl","key":"15098_CR49","first-page":"S406","volume":"50","author":"W Dq","year":"2009","unstructured":"Dq W, De C, Mc C. Biliary lipids and cholesterol gallstone disease. J Lipid Res. 2009;50(Suppl):S406\u201311.","journal-title":"J Lipid Res"},{"key":"15098_CR50","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fimmu.2018.00459","volume":"9","author":"M Genoula","year":"2018","unstructured":"Genoula M, Marin Franco JL, Dupont M, Kviatcovsky D, Millilo A, Schierloh P, et al. Formation of foamy macrophages by tuberculous pleural effusions is triggered by the interleukin-10\/signal transducer and activator of transcription 3 axis through acat upregulation. Front Immunol. 2018;9:459.","journal-title":"Front Immunol"},{"issue":"1","key":"15098_CR51","doi-asserted-by":"publisher","first-page":"e87200","DOI":"10.1371\/journal.pone.0087200","volume":"9","author":"ZY Jiang","year":"2014","unstructured":"Jiang ZY, Cai Q, Chen EZ. Association of three common single nucleotide polymorphisms of ATP binding cassette G8 gene with gallstone disease: a meta-analysis. PloS one. 2014;9(1):e87200.","journal-title":"PloS one."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15098-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-15098-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15098-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T06:03:44Z","timestamp":1675577024000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-15098-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["15098"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-15098-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"10 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Review Board (IERB) of the First Affiliated Hospital of Shihezi University School of Medicine (IERB no.: SHZ2010LL01). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}